Fulgent Genetics, Inc.
FLGT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,826 | -$19,256 | -$11,899 | -$6,190 |
| Dep. & Amort. | $6,038 | $6,054 | $5,919 | $6,192 |
| Deferred Tax | -$701 | $24 | $4 | -$2,126 |
| Stock-Based Comp. | $9,717 | $10,039 | $10,550 | $10,408 |
| Change in WC | $2,384 | -$38,517 | -$9,791 | $16,188 |
| Other Non-Cash | $495 | $11,485 | $786 | $546 |
| Operating Cash Flow | $11,107 | -$30,171 | -$4,431 | $25,018 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6,050 | -$6,826 | -$4,718 | -$3,778 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$18,879 | $0 | $0 | -$98,206 |
| Inv. Sales/Matur. | $40,235 | $60,230 | $32,445 | $74,529 |
| Other Inv. Act. | $3,778 | $0 | $2 | $0 |
| Investing Cash Flow | $19,084 | $53,404 | $27,729 | -$27,455 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$88 | -$88 | -$606 | -$136 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$357 | -$2,550 | -$10,566 | -$242 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $51 |
| Financing Cash Flow | -$445 | -$2,638 | -$11,172 | -$327 |
| Forex Effect | $15 | $4 | $11 | -$134 |
| Net Chg. in Cash | $29,761 | $20,599 | $12,137 | -$2,898 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88,015 | $67,416 | $55,279 | $58,177 |
| End Cash | $117,776 | $88,015 | $67,416 | $55,279 |
| Free Cash Flow | $5,057 | -$36,997 | -$9,149 | $21,240 |